CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape
Authors:
Open Access
- 1 February 2018
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 26 (2) , 342-353
Abstract
No abstract availableKeywords
Funding Information
- SENS Research Foundation
- MRC (MR/K501256/)
This publication has 41 references indexed in Scilit:
- Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyBlood, 2013
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptorsNature Reviews Clinical Oncology, 2013
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target ToxicityMolecular Therapy, 2013
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic LeukemiaScience Translational Medicine, 2013
- A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancerJournal of Translational Medicine, 2012
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cellsBlood, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- Clinical trials for stem cell therapiesBMC Medicine, 2011
- Novel agents for diffuse large B-cell lymphomaExpert Opinion on Investigational Drugs, 2011
- A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian CancerClinical Cancer Research, 2006